Influenza A clinical and preclinical studies, key ..

Nouvel article créé

21 heures - Traduire

Influenza A clinical and preclinical studies, key players, treatment evaluation, emerging therapies, treatment algorithms, pipeline analysis | Cidara Therapeutics, SAb Biotherapeutics, FluGen, Moderna, Vir Biotechnology, Vaxart | #influenza

Influenza A clinical and preclinical studies, key players, treatment evaluation, emerging therapies, treatment algorithm

According to DelveInsight's analysis, the Influenza A pipeline includes major companies actively working on developing treatments.

Aimer

Commentaire

Partagez

21 heures - Traduire

Influenza A clinical and preclinical studies, key players, treatment evaluation, emerging therapies, treatment algorithm

Langue